Ohio Cannabis Operators Report Growth Two Years After Adult-Use Launch

Revenue Climb Outpaces Early Forecasts

Ohio cannabis operators are reporting year-over-year revenue gains that surpass the state's original fiscal projections. Multiple multi-state operators with Ohio footprints told CannIntel that adult-use sales now represent 60-70% of total revenue at dual-license locations. That's a faster conversion rate than Illinois or Michigan saw during comparable post-launch windows.

The state's Division of Cannabis Control hasn't yet published consolidated 2026 sales data, but dispensary-level reporting suggests statewide monthly sales are tracking above $120 million as of May 2026. That figure would put Ohio on pace to exceed $1.4 billion in annual adult-use sales by year-end, roughly 15% above the Legislative Service Commission's 2024 forecast.

Cultivation Capacity Expands to Meet Demand

Licensed cultivators have added over 500,000 square feet of canopy since adult-use launch, according to DCC facility records. The expansion has kept wholesale flower prices stable—averaging $1,200-$1,400 per pound for premium indoor—while preventing the supply gluts that plagued early recreational markets in Oregon and Colorado.

Ohio's phased licensing approach and cultivator caps have created a supply-demand equilibrium that benefits both growers and retailers, a dynamic rarely seen in first-generation adult-use states.

Smaller craft cultivators report consistent sell-through rates. Margins are improving. One central Ohio grower said wholesale contracts now extend 90-120 days out, compared to spot-market dynamics that dominated the medical-only era.

Patient Numbers Hold Steady Despite Adult-Use Shift

Ohio's medical cannabis registry has retained approximately 85,000 active patients, down only 12% from pre-adult-use levels. That retention rate is stronger than Michigan's, where medical enrollment dropped 35% in the first two years post-adult-use, and it suggests that tax advantages and higher possession limits are keeping core patients in the medical program.

Medical patients in Ohio pay no excise tax and can purchase up to a 90-day supply, compared to the 2.5-ounce adult-use limit and 10% excise tax. Dispensaries report that chronic-pain and cancer patients have remained loyal to medical cards, while occasional users have migrated to adult-use purchases.

What Operators Are Watching Next

The next inflection point is interstate commerce and federal rescheduling, both of which could reshape Ohio's competitive environment. If DEA finalizes its proposed move of cannabis to Schedule III, Ohio cultivators with strong cash positions will gain access to traditional banking and 280E relief, potentially accelerating M&A activity.

For full background on Ohio's regulatory framework and market structure, see the CannIntel topic hub on Ohio's adult-use program.

Operators are also tracking whether Ohio legislators will lift the current cultivator license cap. The state issued 34 Tier I and Tier II cultivation licenses in the initial wave; a second round could dilute margins but also attract out-of-state capital. We're watching three indicators: DCC's Q3 supply-adequacy report, wholesale price trends through harvest season, and any legislative movement on interstate commerce compacts.